Covid 19 Vaccination

  • Unique Paper ID: 153018
  • Volume: 8
  • Issue: 5
  • PageNo: 461-465
  • Abstract:
  • The current COVID-19 pandemic has urged the scientific community throughout the world to find a cure for the disease therapeutics and vaccines to control SARS-CoV-2. Some of the published investigations mostly on SARS-CoV and on MERS have taught lessons on developing the vaccination strategies for this novel coronavirus. It has also revealed the fact that SARS-CoV-2 uses the same receptor as SARS-CoV on the human cell and is approximately 80% similar genetically to SARS-CoV. Although the efforts on COVID-19 vaccines started very early, initially in China, as soon as the outbreak of coronavirus started and then world-over as the disease was declared a pandemic by WHO. But we got the vaccine at a very later stage. This is because a COVID-19 vaccine will require validation of efficacy y because the target vaccine population includes high-risk individuals i.e senior citizens, over the age of 60, particularly those with co-morbid conditions, frontline healthcare workers etc. Various types of vaccine development are available namely: virus vectored vaccines, genetic vaccines, and monoclonal antibodies , protein subunit vaccines, for passive immunization. The COVID-19 pandemic is the most devastating one in the last 100 years after the Spanish flu which requires the speedy evaluation of the various approaches for competence to provide protective immunity and safety. This review is aimed at providing an overview of the efforts dedicated to an effective vaccine for this novel coronavirus which has crippled the entire world in terms of life, economy, and human health

Cite This Article

  • ISSN: 2349-6002
  • Volume: 8
  • Issue: 5
  • PageNo: 461-465

Covid 19 Vaccination

Related Articles